Search results for "influenza"
Article
Vaccine Development and Production Challenges Manufacturers
…o market new products to combat dangerous infections and strategies to improve supplies of seasonal influenza shots. Vaccine development was discussed as important for global security at the World Ec…
Article
Bioprocessing Advances in Vaccine Manufacture
For example, Project GreenVax, a private–public consortium, is currently constructing an influenza vaccine manufacturing facility (to be operated by G-Con, developer of the modular units being used) i…
Article
A Look at the Affinity Chromatography Landscape
It is useful for the capture of several virus types including influenza, Japanese encephalitis, measles, and viral antigens from Hepatitis B.
“This sulfated cellulose membrane adsorber exhibits…
Article
Ensuring Viral Safety of Viral Vaccines and Vectors
Chemical processes are typical, as with poliomyelitis and influenza viruses, and often utilize β-propylactone (BPL) or formalin (formaldehyde). Insect cell-based processes can produce 1010–12 baculovi…
Article
Microbiological Testing: Time is of the Essence
Vaccines drive test development
The need for a rapid response to a possible influenza pandemic in the first decade of the 2000s spurred the development of RMMs, according to McKee. Alternative stra…
Article
Vaccine Development Faces Urgency and Challenges
Efforts to establish more reliable and efficient supplies of seasonal influenza vaccine in the United States, moreover, have led to development and FDA approval of the first US adjuvant flu vaccine.
…
Article
Pharma Investments Reflect Key Industry Trends
GSK is selling its oncology business to Novartis and buying Novartis’ vaccines business (excluding influenza vaccines), and the two companies are combining their over-the-counter businesses.
In Ma…
Article
Can Vaccine Development Be Safely Accelerated?
The technology is used for Sanofi’s licensed recombinant influenza vaccine and a SARS vaccine that has been shown in non-clinical studies to be immunogenic and afford partial protection in animal chal…
Article
Scalable ADCF Virus Production Using HyClone™ VaccineXpress Medium
In this study, HyClone VaccineXpress cell culture medium was used for the propagation of influenza virus and rotavirus in an animal-derived component-free (ADCF) process. Small-scale microcarrier cu…
Article
The Challenge of Disruptive Technologies in Bioprocessing
“The use of mAbs for Alzheimer’s disease (Biogen), influenza (VIR), or as neutralizing antibodies for HIV (JustBio) are examples where such demand could come up,” Jagschies says.
Other drivers …